The protein expression of IFITM1, IFITM2, or IFITM3 are predictors for poor prognosis in numerous cancers such as colorectal (104, 105, 106), prostate (107), ovarian (108), lung (109), liver (26), breast (7, 110), and astrocytoma (111). Here, IFITM1 is linked to cancer.